Calcium deposit in bursa

M13_CALCBURS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M71.4 Cause of death: ICD-10 — M71.4 2 out of 7 registries used, show all original rules.	81
4. Check minimum number of events None	81
5. Include endpoints None	81
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M71
Name in latin: Calcificatio bursae

NAME	M13_CALCBURS
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M714
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M714
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Calcium deposit in bursa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	441	216	224
Only index persons	420	209	211
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	54.38	54.77	53.91
Only index persons	53.77	54.21	53.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	42	35
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	52.82	50.59	55.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
77: Matched controls
770

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M71.4

ICD-10 Finland

Calcium deposit in bursa

+∞

110.7

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

+∞

11.8

NBG10

NOMESCO Finland

Acromioplastia

113.4

9.6

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

44.1

6.9

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.1

6.5

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

8.4

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

2.87

3.72

2.1

1.5

—

(3023368) Bacteria identified in Blood by Culture

169

2.53

3.69

5.8

4.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.92

3.32

2.0

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

10.56

3.02

5.0

5.2

1.40

1.60

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

5.80

2.94

1.3

1.2

—

(3019060) Gas panel - Arterial blood

3.12

2.79

4.8

3.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

7.53

2.58

1.0

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

328

2.11

2.55

9.0

5.4

1.97

1.73

e9/l

0.90

296

(3019977) pH of Arterial blood

2.51

2.54

14.8

7.3

7.43

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.76

2.34

2.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3.94

2.21

2.9

3.8

26.66

26.96

mmol/l

—

(3001604) Monocytes [#/volume] in Blood

323

1.95

2.11

7.9

5.5

0.61

0.58

e9/l

0.29

277

(3006315) Basophils [#/volume] in Blood

325

1.93

2.05

8.5

5.5

0.05

0.04

e9/l

2.01

276

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2.79

2.03

5.8

3.2

5.54

5.31

kpa

—

(40768804) Tissue Pathology biopsy report

279

1.90

2.02

2.0

2.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

282

1.87

1.93

2.1

1.9

93.59

95.58

pmol/l

0.12

149

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

294

1.84

1.85

4.2

2.6

—

estimate

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

4.37

1.85

1.2

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.24

1.85

2.0

1.9

—

(3013115) Eosinophils [#/volume] in Blood

334

1.84

1.80

8.8

5.7

0.19

0.17

e9/l

0.28

293

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

154

1.92

1.80

3.8

2.1

—

(3022313) Gas panel - Capillary blood

3.10

1.77

3.9

2.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2.72

1.74

2.0

2.2

0.80

2.05

g/l

—

(3017732) Neutrophils [#/volume] in Blood

2.22

1.72

6.9

2.2

4.17

5.22

e9/l

0.74

(3044640) Blood type and Crossmatch panel - Blood

208

1.82

1.70

4.0

2.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

3.16

1.61

1.0

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3.16

1.61

1.2

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

211

1.79

1.61

2.9

2.1

60.81

81.42

u/l

0.40

196

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.59

1.59

25.5

7.2

26.01

25.58

mmol/l

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

195

1.78

1.56

3.2

2.2

346.76

175.75

u/l

0.32

185

(42870588) Differential panel, method unspecified - Blood

213

1.76

1.55

7.8

5.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.49

1.55

1.0

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2.25

1.47

3.1

2.4

117.45

151.53

ng/l

0.28

(3021440) Promyelocytes/Leukocytes in Blood

2.21

1.41

6.0

3.2

0.33

0.27

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2.74

1.39

1.3

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

3.07

1.38

6.6

2.8

7.72

8.10

kpa

—

(40768443) Skin Pathology biopsy report

2.43

1.31

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.74

1.23

1.2

—

(40768797) Stomach Pathology biopsy report

1.88

1.22

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.46

1.16

2.3

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

2.01

1.14

6.1

3.1

1.08

1.25

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

364

1.57

1.10

9.8

11.6

4.56

4.23

e9/l

0.31

320

(3002179) Metamyelocytes/Leukocytes in Blood

2.02

1.07

6.4

3.4

1.00

0.73

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.80

0.99

2.5

5.0

300.77

245.71

u/l

0.49

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.98

0.97

27.3

8.9

0.51

0.67

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.83

0.96

1.6

1.7

441.56

413.62

nmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.84

0.92

2.5

2.1

1.77

1.35

1.93

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.82

0.85

2.0

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

367

1.46

0.85

3.8

3.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.92

0.76

27.3

8.5

1.61

1.62

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.65

0.74

5.0

3.7

5.57

5.63

kpa

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.07

0.74

1.2

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

507

1.48

0.73

3.8

3.9

14.24

14.93

pmol/l

1.32

462

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

642

1.72

0.72

4.9

4.3

1.24

1.25

mmol/l

0.02

600

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.62

0.71

3.9

2.4

17.80

22.08

0.70

(4024509) Urine culture

1.91

0.70

2.2

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

520

1.47

0.69

11.8

7.7

81.03

78.71

u/l

0.23

491

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.57

0.66

15.6

7.0

104.31

105.17

mmol/l

0.18

(3026008) Bacteria identified in Urine by Culture

186

1.42

0.65

3.3

2.7

—

(3000991) Gas panel - Venous blood

1.63

0.63

27.0

8.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

124

1.48

0.62

2.2

1.9

—

(4034850) Laboratory test

0.00

0.61

0.0

11.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.60

0.0

1.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.67

0.57

31.7

9.0

95.42

90.91

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.48

0.55

1.2

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

258

1.34

0.54

4.8

3.6

25.39

35.30

ng/l

0.50

183

(1761868) Lipid panel - Serum or Plasma

271

0.74

0.52

2.7

3.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

654

1.53

0.50

30.1

14.0

31.87

24.29

mg/l

0.73

531

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

104

1.42

0.47

1.9

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.65

0.44

1.4

1.0

—

(3022145) Colonoscopy Study observation

1.46

0.43

1.1

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.6

—

69.27

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.41

0.0

2.3

—

158.18

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.50

0.41

1.4

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.39

0.40

4.2

3.1

—

(3009508) Creatinine [Moles/volume] in Urine

240

1.26

0.38

3.1

7.17

7.56

mmol/l

0.22

200

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

232

1.25

0.35

5.1

2.7

42.41

30.20

u/l

1.54

222

(3013512) EKG study

223

1.25

0.34

6.2

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

672

1.46

0.33

32.9

16.4

139.46

139.90

mmol/l

0.89

659

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.35

0.32

1.0

1.3

—

(3000492) Spirometry study

1.35

0.29

1.3

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

559

1.24

0.27

28.7

18.2

329.78

331.74

g/l

0.98

559

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.69

0.27

1.4

2.0

3.28

3.32

ratio

—

(3012516) Albumin [Mass/volume] in Urine

229

1.20

0.26

3.0

3.2

71.44

83.28

mg/l

0.06

152

(3000494) Fungus identified in Specimen by Culture

1.32

0.25

1.9

1.5

—

(3018095) Leukocytes [#/volume] in Urine

269

1.19

0.25

4.4

3.6

270.15

71.34

e6/l

0.43

185

(40761511) CBC panel - Blood by Automated count

678

1.36

0.24

23.1

13.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

676

1.39

0.24

33.2

16.5

4.00

3.96

mmol/l

0.64

662

(3011397) Hemoglobin [Presence] in Urine by Test strip

155

1.21

0.22

2.9

3.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

46.09

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

21.64

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

5.2

—

13.88

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

6.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.20

0.0

1.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.22

0.20

4.7

3.4

5.77

4.49

kpa

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

119

1.22

0.19

2.1

2.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.25

0.18

12.1

6.1

1.18

1.08

mmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.73

0.17

1.4

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

375

1.14

0.17

9.6

6.3

9.79

11.33

umol/l

0.68

357

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

439

1.12

0.13

5.4

2.9

65.96

47.77

u/l

0.46

415

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

123

1.17

0.13

1.4

—

(3015736) pH of Urine

293

1.10

0.10

3.7

3.0

5.96

6.12

0.28

169

(3020682) Albumin/Creatinine [Ratio] in Urine

235

1.09

0.08

4.0

10.86

15.18

mg/mmol

0.17

147

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.78

0.08

5.4

7.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.08

0.08

1.3

1.7

—

(21494755) Public health laboratory ask at order entry panel

0.80

0.08

1.7

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.11

0.08

2.1

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.05

0.07

2.2

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

240

0.94

0.04

5.8

5.4

1.33

3.23

ug/l

0.80

211

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

240

0.94

0.04

3.8

3.1

—

(3009261) Glucose [Presence] in Urine by Test strip

370

0.95

0.04

4.9

3.3

0.00

estimate

—

(36304419) Bacteria [Presence] in Urine

189

0.94

0.03

3.5

2.8

—

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

362

1.04

0.02

4.4

3.3

0.00

estimate

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

644

1.06

0.01

24.2

14.0

79.85

80.34

ml/min/173m2

0.07

592

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

122

0.98

0.00

3.6

2.6

1.30

1.29

e6/l

—

(3003694) ABO and Rh group [Type] in Blood

192

0.99

0.00

2.0

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

143

0.97

0.00

12.6

5.5

—

(3021589) Normoblasts [#/volume] in Blood

307

1.02

0.00

13.3

13.2

0.01

e9/l

0.18

251

(40758558) Short blood count panel - Blood

205

0.97

0.00

3.6

6.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

199

1.01

0.00

5.1

4.5

25.25

22.46

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

101

0.99

0.00

1.3

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

111

0.99

0.00

3.8

2.8

4.20

1.98

e6/l

—

(3018418) pH of Serum or Plasma

216

1.03

0.00

3.5

4.5

7.40

0.00

159

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

304

0.98

0.00

2.3

1.9

1.28

1.34

mmol/l

0.14

252

(3035350) Ketones [Presence] in Urine by Test strip

366

1.02

0.00

4.8

3.3

0.00

estimate

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

15.5

—

1121.83

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

8.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

0.0

1.0

—

9.17

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

8.3

—

664.33

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

23.2

—

1898.83

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.0

—

10.42

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

720

1.00

-0.00

44.1

22.4

39.48

40.57

0.78

713

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.00

-0.00

2.2

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

719

1.02

-0.00

41.3

22.1

91.48

91.31

0.12

713

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

3.66

—

(3035941) MCH [Entitic mass]

720

1.00

-0.00

41.3

22.0

30.28

30.36

0.13

714

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

720

1.00

-0.00

41.6

22.2

7.01

6.51

e9/l

0.97

709

(3002256) Pathology report gross observation

0.96

-0.00

1.4

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

720

1.00

-0.00

41.6

22.3

132.07

135.28

g/l

1.05

714

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

-0.00

0.0

2.1

—

13.53

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

704

1.11

-0.00

33.4

18.7

85.82

78.05

umol/l

0.33

695

(44806420) Estimation of glomerular filtration rate

0.00

-0.00

0.0

1.9

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

954.60

—

(3007461) Platelets [#/volume] in Blood

719

1.02

-0.00

41.9

22.1

248.83

246.01

e9/l

0.12

711

(3026361) Erythrocytes [#/volume] in Blood

720

1.00

-0.00

41.5

22.1

4.42

4.49

e12/l

0.46

709

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.87

-0.00

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

5.50

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.2

—

3.14

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

697

1.05

-0.00

18.4

11.5

25.07

25.93

u/l

0.22

679

(4035726) Immunohistochemistry procedure

0.98

-0.00

1.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_CALCBURS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_CALCBURS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_CALCBURS – Calcium deposit in bursa

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Calcium deposit in bursa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints